APA (7th ed.) Citation

P, R., IA, M., J, B., H, T., G, W., S, K., . . . B, D. (2024). Exploring the impact of durvalumab on biliary tract cancer: Insights from real-world clinical data. Cancer immunology, immunotherapy : CII, 73(12), 251. https://doi.org/10.1007/s00262-024-03842-y

Chicago Style (17th ed.) Citation

P, Reimann, et al. "Exploring the Impact of Durvalumab on Biliary Tract Cancer: Insights from Real-world Clinical Data." Cancer Immunology, Immunotherapy : CII 73, no. 12 (2024): 251. https://doi.org/10.1007/s00262-024-03842-y.

MLA (9th ed.) Citation

P, Reimann, et al. "Exploring the Impact of Durvalumab on Biliary Tract Cancer: Insights from Real-world Clinical Data." Cancer Immunology, Immunotherapy : CII, vol. 73, no. 12, 2024, p. 251, https://doi.org/10.1007/s00262-024-03842-y.